Windlas Biotech Ltd
NSE:WINDLAS

Watchlist Manager
Windlas Biotech Ltd Logo
Windlas Biotech Ltd
NSE:WINDLAS
Watchlist
Price: 768.6 INR -2.3% Market Closed
Market Cap: ₹16.2B

Net Margin

8.1%
Current
Declining
by 0.5%
vs 3-y average of 8.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
8.1%
=
Net Income
₹673.2m
/
Revenue
₹8.3B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
8.1%
=
Net Income
₹673.2m
/
Revenue
₹8.3B

Peer Comparison

Country Company Market Cap Net
Margin
IN
Windlas Biotech Ltd
NSE:WINDLAS
16.1B INR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.6B USD
Loading...
US
Danaher Corp
NYSE:DHR
167.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.8B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
276.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.5B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.1B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20B EUR
Loading...

Market Distribution

In line with most companies in India
Percentile
60th
Based on 5 531 companies
60th percentile
8.1%
Low
-305 007.7% — 2.1%
Typical Range
2.1% — 11.6%
High
11.6% — 1 221 633.3%
Distribution Statistics
India
Min -305 007.7%
30th Percentile 2.1%
Median 5.8%
70th Percentile 11.6%
Max 1 221 633.3%

Windlas Biotech Ltd
Glance View

Windlas Biotech Ltd. operates as a contract development and manufacturing organization (CDMO). The firm provides a range of contract development and manufacturing organization (CDMO) services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics. Its therapeutic categories, such as, anti-diabetic, cardiovascular, neuropsychiatry and respiratory therapies. The Company’s service capabilities include formulation development, technology scale-up and full-scale commercial manufacturing. The company has capabilities for both solid and liquid pharmaceutical dosage forms. The Company’s market its own manufactured nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities. The company also has a salesforce and distribution network spread across over 14 states. The Company’s manufacturing facilities are located at Dehradun in Uttarakhand.

WINDLAS Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
8.1%
=
Net Income
₹673.2m
/
Revenue
₹8.3B
What is Windlas Biotech Ltd's current Net Margin?

The current Net Margin for Windlas Biotech Ltd is 8.1%, which is below its 3-year median of 8.6%.

How has Net Margin changed over time?

Over the last 3 years, Windlas Biotech Ltd’s Net Margin has decreased from 9.2% to 8.1%. During this period, it reached a low of 8% on Mar 31, 2025 and a high of 9.3% on Dec 31, 2022.

Back to Top